Source: International Congress 2019 – Research and innovation in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. An (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea), H. Won (Seoul, Republic of Korea), W. Song (Seoul, Republic of Korea), H. Kwon (Seoul, Republic of Korea), Y. Cho (Seoul, Republic of Korea), H. Moon (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea). Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma. 4263

Member's Comments

No comment yet.

Related content which might interest you: The diagnostic value of biomarkers in allergic and non-allergic asthma phenotype Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018 Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Reactance for bronchial reactivity is a useful clinical marker in differentiating cough-variant asthma from classic asthma Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008 Free serum IgE suppression with omalizumab and clinical outcomes in asthma Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021 Effect of urbanisation on the relationship between total serum IgE and asthma Source: Eur Respir J 2013; 41: 1074-1081 Year: 2013 Capability of classical diagnostic procedure in relation with specific inhalation challenge for conclusive diagnosis in allergic asthma Source: Annual Congress 2008 - Asthma and inhalation injuries at work Year: 2008 Inflammatory biomarkers in the evaluation of two-year  outcomes  of omalizumab treatment in severe allergic asthma. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Significance of microRNAs in allergic asthma patients. Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Serum proteome analysis discriminates allergic rhinitis from asthma Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults Source: ERJ Open Res, 7 (4) 00293-2021; 10.1183/23120541.00293-2021 Year: 2021 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 The evaluation and biomarkers of severe asthma Source: Annual Congress 2010 - Severe asthma: reviewing the last decade and looking to the next. A report of the ERS/ATS Task Force Year: 2010 Epidemiology of serum IgE in children with allergic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 373s Year: 2001 Characterisation of a chronic pre-clinical model of allergic asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 The role of Hs-CRP in evaluating asthma severity and asthma control Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Elevated serum ECP in wheezing infants predicts the development of atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 192s Year: 2002